InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Schenkein David P, Director. Officer active across 3 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 9 disclosures have been logged. The latest transaction was filed on 2 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
05,986 shares0
Common Stock
SEC:0001714899-22-000098:0·
01,585 shares0
Common stock
SEC:0001439222-22-000051:0·
02,775 shares0
Common stock
SEC:0001439222-22-000015:0·
02,074 shares0
Common Stock
SEC:0001209191-21-038390·
02,074 shares0
Common Stock
SEC:0001209191-21-038390:0·
03,253 shares0
Common Stock
SEC:0001209191-21-038047·
03,253 shares0
Common Stock
SEC:0001209191-21-038047:0·
01,686 shares0
Common stock
SEC:0001439222-21-000050·
01,686 shares0
Common stock
SEC:0001439222-21-000050:0·
9 of 9 declarations
About Schenkein David P
David P. Schenkein is a Director at AGIOS PHARMACEUTICALS, INC. and Denali Therapeutics Inc. He contributes to the governance of the companies and strategic decision-making. His expertise in the pharmaceutical sector allows him to make significant contributions to the companies' leadership.
